Correspondence 0000950170-24-042692 from Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc.
Date: April 8, 2024 · CIK: 0001671584 · Accession: 0000950170-24-042692
AI Filing Summary & Sentiment
File numbers found in text: 333-278103
Show Raw Text
CORRESP 1 filename1.htm CORRESP Roth Capital Partners, LLC 888 San Clemente Drive Newport Beach, CA 92660 April 8, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Aptevo Therapeutics Inc. (the “Company”) Registration Statement on Form S-1 (File No. 333-278103) Ladies and Gentlemen: In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Roth Capital Partners, LLC, as placement agent, hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 5:00 p.m. (Eastern time) on Tuesday, April 9, 2024 or as soon thereafter as practicable. In making this request the undersigned acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to the registration statement. [Signature Page Follows] Very truly yours, ROTH CAPITAL PARTNERS, LLC, By: /s/ Aaron M. Gurewitz Name: Aaron M. Gurewitz Title: President & Head of Investment Banking